Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- presença de fatores de risco
- crescimento da lesão ao longo de semanas a meses
- pápula arredondada, saliente
- pequenos pontos pretos na superfície da lesão
Outros fatores diagnósticos
- lesões satélites
- lesões nos dedos ou nas dobras ungueais
- lesões faciais
- fissuras
- hiperceratose
- coloração branca-acinzentada ou marrom claro
- pápula filiforme com espículas pontiagudas
Fatores de risco
- imersão em água
- profissões que envolvem o manuseio de carne ou peixe
- roer unhas
- idade abaixo de 35 anos
- imunocomprometido
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- nenhum exame inicial
Investigações a serem consideradas
- biópsia de pele
- coloração com imunoperoxidase
- cultura da pele
Algoritmo de tratamento
verruga comum: imunocompetente
verruga comum: imunocomprometido
verruga filiforme
Colaboradores
Autores
Angela Yen Moore, MD
Director
Arlington Center of Dermatology
Primary Investigator
Arlington Research Center
Arlington
Clinical Assistant Professor
Baylor University Medical Center
Dallas
Clinical Assistant Professor
University of Texas Medical Branch
Galveston
TX
Divulgaciones
Dr. Moore receives funds as an advisory board member (A), consultant (C), clinical study investigator (I), and speaker (SP) – for Abbvie (I,SP), Almirall (C,I,SP), Arcutis (I), Biofrontera (C,I), Boehringer Ingelheim (I), Bristol-Myers Squibb (C,I), Dermavant (I), DS Biopharma (I), Eli Lilly (I), EpiHealth (A), Evolus (A), Galderma (I), Incyte (I), Janssen (I), Leo (A,SP), Mayne Pharma (C,I), Nimbus (I), Novartis (I), Parexel (I), Pfizer (I,SP), UCB (I), Verrica (I), Vyne (I,SP).
Agradecimientos
Dr Angela Yen Moore would like to gratefully acknowledge Dr Leonid Izikson, the previous contributor to this topic. LI declares that he has no competing interests.
Revisores por pares
Brenda L. Pellicane, MD
Dermatologist
Wayne State University School of Medicine
Department of Dermatology
Detroit
MI
Divulgaciones
BLP declares that she has no competing interests.
David Cassarino, MD, PhD
Assistant Professor
Department of Pathology and Laboratory Medicine
University of California
Los Angeles
CA
Divulgaciones
DC declares that he has no competing interests.
Jashin J. Wu, MD
Chief Dermatology Resident
University of California
Irvine
CA
Divulgaciones
JJW declares that he has no competing interests.
Sam Gibbs, FRCP
Consultant Dermatologist
Dermatology Department
The Great Western Hospital
Swindon
UK
Divulgaciones
SG declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006;4:273-293.Texto completo Resumen
Gibbs S, Harvey I, Sterling J, et al. Local treatments for cutaneous warts: systematic review. BMJ. 2002;325:461.Texto completo Resumen
Kwok CS, Gibbs S, Bennett C, et al. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012;(9):CD001781.Texto completo Resumen
Dall'oglio F, D'Amico V, Nasca MR, et al. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13:73-96. Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Verrugas planas
- Verrugas palmoplantares
- Ceratose seborreica
Más DiferencialesGuías de práctica clínica
- Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV
- Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV
Más Guías de práctica clínicaPatient information
Verrugas (comuns)
Vacina contra o HPV (papilomavírus humano)
More Patient information
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer